[Classical and current aspects of purulent meningitis]

Related Experiment Video

Updated: Nov 4, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

A Ring1, R Novak, F J Schmitz

  • 1Institut für Medizinische Mikrobiologie und Virologie, Heinrich-Heine-Universität, Düsseldorf.

Der Nervenarzt
|August 1, 1996
PubMed

Insights

Acute purulent meningitis remains life-threatening despite antibiotics. New therapies targeting inflammation are crucial to prevent neurological damage and death from this central nervous system infection.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Molecular Biology

Context:

  • Bacterial meningitis is a severe central nervous system (CNS) infection with high mortality rates.
  • Current antibiotic treatments have not reduced mortality over the past two decades.
  • Long-term neurological deficits are common sequelae of bacterial meningitis.

Purpose:

  • To review the current understanding of antibiotic and adjunctive therapies for acute purulent meningitis.
  • To explore the molecular mechanisms of inflammation in CNS infections.
  • To identify potential therapeutic targets for improving outcomes in bacterial meningitis.

Summary:

  • Bacterial meningitis continues to pose a significant threat despite advances in antibiotic therapy.
  • Mortality rates have remained stagnant, highlighting the need for novel treatment strategies.
  • Understanding the molecular pathogenesis of CNS inflammation is key to developing effective adjunctive therapies.
  • This review discusses current therapeutic approaches and their limitations in managing bacterial meningitis.

Impact:

  • Highlights the urgent need for innovative therapeutic strategies beyond conventional antibiotics.
  • Provides insights into the molecular pathophysiology of meningitis, guiding future research.
  • Emphasizes the importance of adjunctive therapies in mitigating inflammation and preventing neurological sequelae.
  • Aims to improve patient outcomes and reduce mortality associated with bacterial meningitis.

More Related Videos

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side09:58

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side

Published on: May 6, 2016

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...